These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28643601)

  • 1. New insights into the burden and costs of multiple sclerosis in Europe: Results for Sweden.
    Brundin L; Kobelt G; Berg J; Capsa D; Eriksson J;
    Mult Scler; 2017 Aug; 23(2_suppl):179-191. PubMed ID: 28643601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the burden and costs of multiple sclerosis in Europe: Results for Portugal.
    Sá MJ; Kobelt G; Berg J; Capsa D; Dalén J;
    Mult Scler; 2017 Aug; 23(2_suppl):143-154. PubMed ID: 28643585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the burden and costs of multiple sclerosis in Europe: Results for Russia.
    Boyko A; Kobelt G; Berg J; Boyko O; Popova E; Capsa D; Eriksson J;
    Mult Scler; 2017 Aug; 23(2_suppl):155-165. PubMed ID: 28643590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary.
    Péntek M; Kobelt G; Berg J; Capsa D; Dalén J; Bíró Z; Mátyás K; Komoly S;
    Mult Scler; 2017 Aug; 23(2_suppl):91-103. PubMed ID: 28643591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the burden and costs of multiple sclerosis in Europe: Results for Italy.
    Battaglia M; Kobelt G; Ponzio M; Berg J; Capsa D; Dalén J;
    Mult Scler; 2017 Aug; 23(2_suppl):104-116. PubMed ID: 28643600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland.
    Selmaj K; Kobelt G; Berg J; Orlewska E; Capsa D; Dalén J;
    Mult Scler; 2017 Aug; 23(2_suppl):130-142. PubMed ID: 28643586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the burden and costs of multiple sclerosis in Europe: Results for the United Kingdom.
    Thompson A; Kobelt G; Berg J; Capsa D; Eriksson J; Miller D;
    Mult Scler; 2017 Aug; 23(2_suppl):204-216. PubMed ID: 28643587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the burden and costs of multiple sclerosis in Europe: Results for Spain.
    Oreja-Guevara C; Kobelt G; Berg J; Capsa D; Eriksson J;
    Mult Scler; 2017 Aug; 23(2_suppl):166-178. PubMed ID: 28643597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the burden and costs of multiple sclerosis in Europe: Results for France.
    Lebrun-Frenay C; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):65-77. PubMed ID: 28643588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the burden and costs of multiple sclerosis in Europe: Results for Switzerland.
    Calabrese P; Kobelt G; Berg J; Capsa D; Eriksson J;
    Mult Scler; 2017 Aug; 23(2_suppl):192-203. PubMed ID: 28643596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the burden and costs of multiple sclerosis in Europe: Results for Germany.
    Flachenecker P; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):78-90. PubMed ID: 28643593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands.
    Uitdehaag B; Kobelt G; Berg J; Capsa D; Dalén J;
    Mult Scler; 2017 Aug; 23(2_suppl):117-129. PubMed ID: 28643595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the burden and costs of multiple sclerosis in Europe: Results of the Czech Republic.
    Havrdova E; Kobelt G; Berg J; Capsa D; Gannedahl M; Doležal T;
    Mult Scler; 2017 Aug; 23(2_suppl):41-52. PubMed ID: 28643584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the burden and costs of multiple sclerosis in Europe: Results for Denmark.
    Rasmussen PV; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):53-64. PubMed ID: 28643589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the burden and costs of multiple sclerosis in Europe: Results for Austria.
    Berger T; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):17-28. PubMed ID: 28643599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the burden and costs of multiple sclerosis in Europe: Results for Belgium.
    Dubois B; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):29-40. PubMed ID: 28643598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of multiple sclerosis 2015: Methods of data collection, assessment and analysis of costs, quality of life and symptoms.
    Kobelt G; Eriksson J; Phillips G; Berg J
    Mult Scler; 2017 Aug; 23(2_suppl):4-16. PubMed ID: 28643592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.